United States of America– [6-February-2026]-
The inflammatory bowel disease treatment represents a critical segment within the life sciences industry, driven by the growing burden of chronic gastrointestinal disorders worldwide. Inflammatory bowel disease includes Crohn’s disease and ulcerative colitis, both of which require long term disease management and continuous therapeutic intervention.
Comments